Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- DOI
- 10.1002/acr2.11185
- Published
- 2020 Nov
- Container
- ACR open rheumatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/acr2.11185,
title = {Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.},
author = {Merkel PA and Niles J and Jimenez R and Spiera RF and Rovin BH and Bomback A and Pagnoux C and Potarca A and Schall TJ and Bekker P and CLASSIC Investigators},
year = {2020},
journal = {ACR open rheumatology},
doi = {10.1002/acr2.11185},
url = {https://doi.org/10.1002/acr2.11185}
}RIS
TY - JOUR TI - Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. AU - Merkel PA AU - Niles J AU - Jimenez R AU - Spiera RF AU - Rovin BH AU - Bomback A AU - Pagnoux C AU - Potarca A AU - Schall TJ AU - Bekker P AU - CLASSIC Investigators PY - 2020 JO - ACR open rheumatology DO - 10.1002/acr2.11185 UR - https://doi.org/10.1002/acr2.11185 ER -
APA
PA, M., J, N., R, J., RF, S., BH, R., A, B., C, P., A, P., TJ, S., P, B., & Investigators, C. (2020). Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.. ACR open rheumatology. https://doi.org/10.1002/acr2.11185
Source records
- pubmed · retrieved 2026-09-27T14:33:04.450Z